Search Results - "Lozano-Rabella M"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    1080TiP An investigator-initiated phase I study to assess the safety and tolerability of ex vivo next-generation neoantigen-selected tumor-infiltrating lymphocyte (TIL) therapy in advanced immune checkpoint blockade (ICB) resistant solid tumors (NEXTGENTIL-ACT)

    Authors: Galvao, V. Palomero, J. Creus-Gonzalez, I. et al.

    Source: Annals of Oncology. 2023 Supplement 2, Vol. 34, pS650-S650. 1p.

    Save to List
  2. 2

    Identification of clinically relevant T cell receptors for personalized T cell therapy using combinatorial algorithms.

    Authors: Pétremand R Chiffelle J Bobisse S et al.

    Source: Nature biotechnology [Nat Biotechnol] 2025 Mar; Vol. 43 (3), pp. 323-328. Date of Electronic Publication: 2024 May 07.

    Publication Type: Journal Article

    Journal Info: Publisher: Nature America Publishing Country of Publication: United States NLM ID: 9604648 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-1696 (Electronic) Linking ISSN: 10870156 NLM ISO Abbreviation: Nat Biotechnol Subsets: MEDLINE

    Save to List
  3. 3

    Author Correction: Identification of clinically relevant T cell receptors for personalized T cell therapy using combinatorial algorithms.

    Authors: Pétremand R Chiffelle J Bobisse S et al.

    Source: Nature biotechnology [Nat Biotechnol] 2025 Mar; Vol. 43 (3), pp. 445.

    Publication Type: Published Erratum

    Journal Info: Publisher: Nature America Publishing Country of Publication: United States NLM ID: 9604648 Publication Model: Print Cited Medium: Internet ISSN: 1546-1696 (Electronic) Linking ISSN: 10870156 NLM ISO Abbreviation: Nat Biotechnol Subsets: MEDLINE; PubMed not MEDLINE

    Save to List
  4. 4

    Preclinical data and design of a phase I clinical trial of neoantigen-reactive TILs for advanced epithelial or ICB-resistant solid cancers.

    Authors: Palomero J Galvao V Creus I et al.

    Source: Immuno-oncology technology [Immunooncol Technol] 2024 Dec 02; Vol. 25, pp. 101030. Date of Electronic Publication: 2024 Dec 02 (Print Publication: 2025).

    Publication Type: Journal Article

    Journal Info: Publisher: Elsevier Ltd Country of Publication: England NLM ID: 9918281581106676 Publication Model: eCollection Cited Medium: Internet ISSN: 2590-0188 (Electronic) Linking ISSN: 25900188 NLM ISO Abbreviation: Immunooncol Technol Subsets: PubMed not MEDLINE

    Save to List
  5. 5

    Exploring the Immunogenicity of Noncanonical HLA-I Tumor Ligands Identified through Proteogenomics.

    Authors: Lozano-Rabella M Garcia-Garijo A Palomero J et al.

    Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2023 Jun 13; Vol. 29 (12), pp. 2250-2265.

    Publication Type: Editorial; Research Support, Non-U.S. Gov't; Comment

    Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

    Save to List
  6. 6

    Biomarkers of tumor-reactive CD4+ and CD8+ TILs associate with improved prognosis in endometrial cancer.

    Authors: Palomero J Panisello C Lozano-Rabella M et al.

    Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2022 Dec; Vol. 10 (12).

    Publication Type: Journal Article; Research Support, Non-U.S. Gov't

    Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

    Save to List
  7. 7

    TCR Repertoire Changes during TIL Expansion: Clonal Selection or Drifting?

    Authors: Lozano-Rabella M Gros A

    Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2020 Aug 15; Vol. 26 (16), pp. 4177-4179. Date of Electronic Publication: 2020 Jun 09.

    Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Comment

    Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

    Save to List

Search Tools: